Development of a Clinical and Biological Database Monocentric and Prospective in Peritoneal Carcinosis
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 600
- 试验地点
- 1
- 主要终点
- Proportion of patients who gave their consent to participate in the study
研究概览
简要总结
The creation of a prospective clinical-biological base dedicated to peritoneal carcinosis must therefore be able to serve as a support for this essential search for transfer.
详细描述
The main objective is to improve the knowledge of carcinosis mechanisms to develop a specific treatment.
That's why this blood collection and tissue collection is very important for the future, these collection will be permitted to the scientists to develop a research specially for carcinosis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient over the age of 18;
- •Patient managed for peritoneal carcinosis : digestives origins (pancreatic, gastroesophageal junction, colorectal, bowel) or peritoneum cancer
- •Patient eligible for a peritoneal carcinosis treatment : at least one (or more) surgery (s) ;chemotherapy or any treatment for this disease
- •Patient agree will all study procedure : biological samples & tissues samples
- •Patient giving informed consent
排除标准
- •Patient not affiliated to Social Protection system
- •Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons
- •The level of French is insufficient to consent to the study and to response to the questionnaires
- •Patient under guardianship
- •Pregnancy ou breast-feeding women
- •Patient treated in case of an emergency
研究组 & 干预措施
Tumors and blood collection
For all the patients include in the study :
- Blood samples will be collected at different times : before any treatment, at every surgery, one month after any surgery, at progression.
- Tumours and not tumours tissues will be collected at different times : Before any surgery, one month after any surgery
In parallel to this biological collection, standardized clinical data will be entered into a database treatment, at every surgery
干预措施: biological collection (Biological)
Tumors and blood collection
For all the patients include in the study :
- Blood samples will be collected at different times : before any treatment, at every surgery, one month after any surgery, at progression.
- Tumours and not tumours tissues will be collected at different times : Before any surgery, one month after any surgery
In parallel to this biological collection, standardized clinical data will be entered into a database treatment, at every surgery
干预措施: Tissues collections (Other)
结局指标
主要结局
Proportion of patients who gave their consent to participate in the study
时间窗: Until the study completion: 4 years
The proportion of patients who consent to participate in the study among the screened patients
次要结局
未报告次要终点